Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

CHICAGO — The federal corruption trial of former Illinois House Speaker Michael Madigan and longtime political advisor Michael McClain is now passing the 16-week mark. The case remains in ...

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide. Topline results from the Phase 2b ...

The 26-week ... weight loss than Trulicity. But the market expects Novo Nordisk to add further billions to its revenue should semaglutide get approved in a daily pill form. The 26-week trial ...

Reduces A1C levels by 1.9% to 2.2% over 40 weeks. Participants also lost 12 to 15 pounds in clinical trials, though it’s not a weight loss medication ... Rybelsus is a GLP-1 agonist with semaglutide, ...